IMBYODIF Trademark

Trademark Overview


On Thursday, July 1, 2021, a trademark application was filed for IMBYODIF with the United States Patent and Trademark Office. The USPTO has given the IMBYODIF trademark a serial number of 90807748. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, December 28, 2021. This trademark is owned by Summit Therapeutics Inc.. The IMBYODIF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions for the treatment of Clostridioides difficile infection; Pharmaceutical formulations for the treatment of Clostridioides difficile infection; Antibiotics
imbyodif

General Information


Serial Number90807748
Word MarkIMBYODIF
Filing DateThursday, July 1, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, December 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 14, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions for the treatment of Clostridioides difficile infection; Pharmaceutical formulations for the treatment of Clostridioides difficile infection; Antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, December 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSummit Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameSummit Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, December 28, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, December 28, 2021ABANDONMENT - AFTER PUBLICATION
Monday, December 20, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Friday, October 1, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 14, 2021PUBLISHED FOR OPPOSITION
Thursday, August 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 10, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, August 10, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 10, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, August 10, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, August 5, 2021ASSIGNED TO EXAMINER
Thursday, August 5, 2021ASSIGNED TO EXAMINER
Thursday, August 5, 2021PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
Thursday, August 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 3, 2021ASSIGNED TO PETITION STAFF
Friday, July 30, 2021TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Monday, July 5, 2021NEW APPLICATION ENTERED IN TRAM